Prevalence of Alzheimer Disease in US States
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
To the Editors: Alzheimer disease dementia (AD) poses increasing challenges to US states, which dedicate substantial resources to AD care. Chief among these services is long-term nursing home care, a service that many, possibly most, persons with AD require during the course of their illness.1–3 Federal and state governments jointly fund, but individual states manage, Medicaid—the only public health insurance program that provides coverage for this care. However, surveillance systems are not available for gauging the scale of these challenges, and it would be extremely difficult to devise mandatory reporting requirements for AD. Using an alternative approach, we estimated the number of adults, age ≥65 years, with AD in each US state and the District of Columbia (DC) from 2010 to 2025. We computed these estimates by applying the annual AD incidence and AD mortality hazard identified in a large, systematically evaluated community to each state’s population, accounting for each state’s age structure, mortality patterns, and other demographic characteristics. The Supplementary material (eAppendix, https://links.lww.com/EDE/A845) provides extensive detail on these computations, outlined below (as well as presenting further background and sensitivity analyses). We obtained AD incidence and mortality data from the Chicago Health and Aging Project (CHAP),4–6 a longitudinal, population-based study of older adults (60% of whom were black, 40% white). Each 3-year, in-home data-collection cycle included identical clinical evaluations for AD dementia of a stratified, random sample. Between 1997 and 2010, 402 cases of incident AD were identified in 2577 evaluations among 1913 persons who had been classified as free of AD at the previous cycle. Criteria for AD were those of the Work Group of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association for probable AD,7 except that persons who met these criteria and had another condition impairing cognition were retained. There were 990 deaths. From these data, we calculated separate annual incidence estimates for 432 groups defined by single year of age (65–100 years); sex, 2 race groups; and 3 education groups. For each state and DC, we applied the incidence estimates computed from CHAP data to the corresponding state subpopulation jointly defined by year of age (beginning with age 65), sex, and calendar year. We then estimated the AD prevalence proportion in each state and DC in each subpopulation jointly defined by year of age, sex, race, and calendar year, incorporating information on the AD and mortality experience of the corresponding birth cohort in previous years. Finally, we multiplied the proportion of prevalent AD by the census estimate of number of people in each age, sex, and race group and summed across groups to obtain total numbers of people with AD. States with larger older adult populations had larger estimated AD prevalences. Between 2010 and 2025, all states, but not DC, are expected to experience double-digit to triple-digit percentage increases in AD prevalence (range, 19% [Pennsylvania] to 116% [Alaska]), with the largest increases occurring in the West and Southeast (Figure 1, e-Table 1, https://links.lww.com/EDE/A845). Some states with the largest predicted percentage increases—California, Florida, and Texas—already have large numbers of adults with the condition. The burden of AD on the AD-free population also will grow: in 2025 older adults with AD are expected to comprise a larger fraction of state populations than they did in 2010 (eTable 2, https://links.lww.com/EDE/A845).FIGURE: Percentage change from 2010 to 2025 in the number of older adults (65 years and older) with AD dementia, by state.Even within age–sex–race–education strata, the experience of the CHAP population might not generalize to state-specific populations or to different points in time. Uncertainty in state population projections contributes additional uncertainty to our estimates. Nonetheless, these limitations are minor compared with the magnitude of the estimated trajectories that portend a substantial increase in the burden of AD on state populations. Jennifer Weuve Liesi E. Hebert Paul A. Scherr Denis A. Evans Rush Institute for Healthy Aging Rush University Medical Center Chicago, IL [email protected]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Self-citationEvans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., Hebert, L. E., Aggarwal, N., Beckett, L. A., Joglekar, R., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.185 · Cited by 370
Self-citationLethality of Alzheimer Disease and Its Impact on Nursing Home Placement
Arrighi, H. M., Neumann, P. J., Lieberburg, I. M., & Townsend, R. J. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31819fe7d1 · Cited by 126
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
Metadata
- Authors
- Weuve, J., Hebert, L. E., Scherr, P. A., & Evans, D. A.
- Venue
- Epidemiology
- Published
- 2015-01
- Volume
- 26
- Issue
- 1
- Pages
- e4-e6
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W2328133047
- Cited by
- 61
- References
- 3
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of Alzheimer Disease in US States. https://app.cochat.ai/papers/10.1097/ede.0000000000000199
- The paper
- Weuve, J., Hebert, L. E., Scherr, P. A., & Evans, D. A. (2015). Prevalence of Alzheimer Disease in US States. Epidemiology. https://doi.org/10.1097/ede.0000000000000199
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.